ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTImmobilized Artificial Membrane HPLC in Drug ResearchAgnes Taillardat-Bertschinger, Pierre-Alain Carrupt, Francesco Barbato, and Bernard TestaView Author Information Institut de Chimie Thérapeutique, Section de Pharmacie, Université de Lausanne, CH-1015 Lausanne, Switzerland, and Dipartimento di Chimica Farmaceutica e Tossicologica, Università degli Studi di Napoli Federico II, I-80131 Naples, Italy Cite this: J. Med. Chem. 2003, 46, 5, 655–665Publication Date (Web):January 30, 2003Publication History Received20 June 2002Published online30 January 2003Published inissue 1 February 2003https://pubs.acs.org/doi/10.1021/jm020265jhttps://doi.org/10.1021/jm020265jreview-articleACS PublicationsCopyright © 2003 American Chemical SocietyRequest reuse permissionsArticle Views1317Altmetric-Citations120LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstract
No takes yet. Share an insight, caveat, or question.
Taillardat‐Bertschinger et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: